IRTC – iRhythm Technologies, Inc.
iRhythm Technologies, Inc.IRTC
$108.33Name : iRhythm Technologies, Inc.
Sector : Healthcare
Industry: Medical Devices
Mark. Cap: $3,390,512,384.00
EPSttm : -4.85
iRhythm Technologies, Inc.
$108.33
1.25%$1.34Float Short %
7.26
Margin Of Safety %
Put/Call OI Ratio
1.03
EPS Next Q Diff
0.59
EPS Last/This Y
1.04
EPS This/Next Y
1.33
Price
108.39
Target Price
109.25
Analyst Recom
1.38
Performance Q
75.38
Relative Volume
0.92
Beta
1.27
Ticker: IRTC
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2024-12-19 | IRTC | 87.78 | 1.40 | 0.00 | 6237 |
| 2024-12-20 | IRTC | 90.43 | 1.40 | 1.32 | 6224 |
| 2024-12-23 | IRTC | 88.68 | 1.98 | 0.17 | 4373 |
| 2024-12-24 | IRTC | 89.37 | 1.97 | 0.50 | 4379 |
| 2024-12-26 | IRTC | 89.98 | 1.97 | 8.00 | 4389 |
| 2024-12-27 | IRTC | 88.92 | 1.97 | 0.03 | 4391 |
| 2024-12-30 | IRTC | 86.9 | 1.88 | 1.50 | 4469 |
| 2024-12-31 | IRTC | 90.16 | 1.88 | 0.20 | 4483 |
| 2025-01-02 | IRTC | 89.34 | 1.87 | 1.70 | 4488 |
| 2025-01-03 | IRTC | 90.84 | 1.89 | 0.04 | 4509 |
| 2025-01-06 | IRTC | 92.18 | 1.90 | 0.01 | 4498 |
| 2025-01-07 | IRTC | 90.57 | 1.80 | 0.25 | 4585 |
| 2025-01-08 | IRTC | 92.98 | 1.68 | 0.12 | 4721 |
| 2025-01-09 | IRTC | 93 | 1.68 | 0.09 | 4721 |
| 2025-01-10 | IRTC | 97.38 | 1.59 | 0.25 | 4844 |
| 2025-01-13 | IRTC | 94.53 | 1.52 | 0.48 | 4945 |
| 2025-01-14 | IRTC | 99.01 | 1.56 | 0.37 | 4975 |
| 2025-01-15 | IRTC | 103.04 | 1.53 | 0.09 | 5019 |
| 2025-01-16 | IRTC | 107.04 | 1.48 | 0.02 | 5089 |
| 2025-01-17 | IRTC | 108.29 | 1.03 | 0.06 | 6025 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2024-12-19 | IRTC | 87.76 | 72.6 | - | -3.00 |
| 2024-12-20 | IRTC | 90.52 | 72.6 | - | -3.00 |
| 2024-12-23 | IRTC | 88.66 | 72.6 | - | -3.00 |
| 2024-12-24 | IRTC | 89.37 | 72.6 | - | -3.00 |
| 2024-12-26 | IRTC | 89.99 | 72.6 | - | -3.00 |
| 2024-12-27 | IRTC | 88.77 | 72.6 | - | -3.00 |
| 2024-12-30 | IRTC | 87.01 | 72.6 | - | -3.00 |
| 2024-12-31 | IRTC | 90.32 | 72.6 | - | -3.00 |
| 2025-01-02 | IRTC | 89.52 | 72.6 | - | -3.00 |
| 2025-01-03 | IRTC | 90.97 | 72.6 | - | -3.00 |
| 2025-01-06 | IRTC | 92.33 | 72.6 | - | -3.00 |
| 2025-01-07 | IRTC | 90.66 | 72.6 | - | -3.00 |
| 2025-01-08 | IRTC | 93.00 | 72.6 | - | -3.00 |
| 2025-01-09 | IRTC | 93.00 | 72.6 | - | -3.00 |
| 2025-01-10 | IRTC | 97.45 | 72.6 | - | -3.00 |
| 2025-01-13 | IRTC | 94.76 | 72.6 | - | -3.00 |
| 2025-01-14 | IRTC | 99.00 | 72.6 | - | -3.00 |
| 2025-01-15 | IRTC | 103.16 | 72.6 | - | -3.00 |
| 2025-01-16 | IRTC | 107.25 | 72.6 | - | -3.00 |
| 2025-01-17 | IRTC | 108.39 | 71.7 | - | -3.00 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2024-12-19 | IRTC | -3.52 | -0.27 | 6.89 |
| 2024-12-20 | IRTC | -3.52 | -0.27 | 6.89 |
| 2024-12-23 | IRTC | -3.42 | -0.27 | 6.89 |
| 2024-12-24 | IRTC | -3.42 | -0.27 | 6.89 |
| 2024-12-26 | IRTC | -3.50 | -0.27 | 7.18 |
| 2024-12-27 | IRTC | -3.52 | -0.27 | 7.18 |
| 2024-12-30 | IRTC | -3.57 | -1.26 | 7.18 |
| 2024-12-31 | IRTC | -3.57 | -1.26 | 7.18 |
| 2025-01-02 | IRTC | -3.40 | -1.26 | 7.18 |
| 2025-01-03 | IRTC | -3.50 | -1.26 | 7.18 |
| 2025-01-06 | IRTC | -3.19 | -1.32 | 7.18 |
| 2025-01-07 | IRTC | -3.19 | -1.32 | 7.18 |
| 2025-01-08 | IRTC | -3.24 | -1.32 | 7.18 |
| 2025-01-09 | IRTC | -3.24 | -1.32 | 7.18 |
| 2025-01-10 | IRTC | -3.24 | -1.32 | 7.18 |
| 2025-01-13 | IRTC | -3.24 | -0.47 | 7.26 |
| 2025-01-14 | IRTC | -3.24 | -0.47 | 7.26 |
| 2025-01-15 | IRTC | -3.24 | -0.47 | 7.26 |
| 2025-01-16 | IRTC | -3.24 | -0.47 | 7.26 |
| 2025-01-17 | IRTC | -3.24 | -0.47 | 7.26 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.26
Avg. EPS Est. Current Quarter
-0.23
Avg. EPS Est. Next Quarter
-0.67
Insider Transactions
-3.24
Institutional Transactions
-0.47
Beta
1.27
Average Sales Estimate Current Quarter
157
Average Sales Estimate Next Quarter
153
Fair Value
Quality Score
37
Growth Score
52
Sentiment Score
69
Actual DrawDown %
62.1
Max Drawdown 5-Year %
-84.4
Target Price
109.25
P/E
Forward P/E
PEG
P/S
6.05
P/B
47.23
P/Free Cash Flow
EPS
-4.85
Average EPS Est. Cur. Y
-3
EPS Next Y. (Est.)
-1.67
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-26.9
Relative Volume
0.92
Return on Equity vs Sector %
-229
Return on Equity vs Industry %
-222.5
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
iRhythm Technologies, Inc.Sector: Healthcare
Industry: Medical Devices
Employees: 2000
iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
stock quote shares IRTC – iRhythm Technologies, Inc. Stock Price stock today
news today IRTC – iRhythm Technologies, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch IRTC – iRhythm Technologies, Inc. yahoo finance google finance
stock history IRTC – iRhythm Technologies, Inc. invest stock market
stock prices IRTC premarket after hours
ticker IRTC fair value insiders trading